Tamboran Resources Corporation

Falcon Oil & Gas announced that its Shenandoah SS2-1H well achieved an average 20-day initial production flow rate of 10.3 MMcf/d, with normalized rates of 11.9 MMcf/d per 10,000 feet, comparing favorably to Marcellus Shale performance. The company has reduced its participating interest in the well to 0% with no cost exposure. Three additional we...

Falcon Oil & Gas announced that its transaction with Tamboran Resources was approved by shareholders on March 11, 2026. However, the deal faces uncertainty as a court hearing scheduled for March 13 was adjourned to March 24 due to opposition from shareholder Lamesa Holding S.A. The transaction remains subject to multiple conditions including cour...

Falcon Oil & Gas shareholders approved a transaction with Tamboran Resources Corporation with 99.76% of votes cast in favor on March 11, 2026. The transaction remains subject to court approval, NYSE listing authorization, and other standard closing conditions, with expected completion around March 16, 2026. Upon completion, Falcon's shares will b...

Investor rights law firm Halper Sadeh LLC is investigating four companies for potential securities law violations and breaches of fiduciary duties related to proposed mergers and acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting competing offers.

Monteverde & Associates PC is investigating four merger and acquisition transactions involving RAPT Therapeutics, Amicus Therapeutics, Tamboran Resources, and Contango Ore. The firm is encouraging shareholders to act before upcoming votes and tender offer deadlines in March 2026, citing concerns about the proposed deals.